Seeking Alpha

Generic drug maker Lupin Pharmaceuticals launches its Fenofibrate Tablets in the U.S. after...

Generic drug maker Lupin Pharmaceuticals launches its Fenofibrate Tablets in the U.S. after receiving final approval from the FDA. Fenofibrate is the generic equivalent of Abbott's (ABT -0.1%) Tricor tablets, and are for the treatment of Hypercholesterolemia, Mixed Dyslipidemia and Severe Hypertriglyceridemia. Tricor currently represents about a $1.26B market for ABT.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs